Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
PGA4 |
pepsinogen 4, group I (pepsinogen A) |
Mapped by significant region |
IEA
|
PLA2G4B |
phospholipase A2, group IVB (cytosolic) |
Mapped by PBA pathway |
TAS[10085124]
|
C6orf58 |
chromosome 6 open reading frame 58 |
Mapped by significant region |
IEA
|
GPX5 |
glutathione peroxidase 5 (epididymal androgen-related protein) |
Mapped by LD-proxy |
IEA
|
IHH |
indian hedgehog |
Mapped by significant region |
NAS
|
MR1 |
major histocompatibility complex, class I-related |
Mapped by significant region |
IEA
|
IL18 |
interleukin 18 (interferon-gamma-inducing factor) |
Mapped by significant region |
TAS
|
ALDOA |
aldolase A, fructose-bisphosphate |
Mapped by CNV |
TAS
|
PRSS8 |
protease, serine, 8 |
Mapped by CNV |
TAS[10077646]
|
PLA1A |
phospholipase A1 member A |
Mapped by PBA pathway |
IEA
|
DEFB135 |
defensin, beta 135 |
Mapped by CNV |
IEA
|
SMPDL3A |
sphingomyelin phosphodiesterase, acid-like 3A |
Mapped by significant region |
NAS
|
RSPO3 |
R-spondin 3 |
Mapped by significant region |
IEA
|
APOL3 |
apolipoprotein L, 3 |
Mapped by CNV |
IEA
|
NPVF |
neuropeptide VF precursor |
Mapped by CNV; Mapped by significant region |
IEA
|
CCL19 |
chemokine (C-C motif) ligand 19 |
Mapped by LD-proxy |
TAS
|
TMEM25 |
transmembrane protein 25 |
Mapped by significant region |
IEA
|
C11orf44 |
chromosome 11 open reading frame 44 |
Mapped by significant region |
IEA
|
PYCARD |
PYD and CARD domain containing |
Mapped by CNV |
IEA
|
VASN |
vasorin |
Mapped by significant region |
IEA
|
PATE1 |
prostate and testis expressed 1 |
Mapped by significant region |
IEA
|
PTX4 |
pentraxin 4, long |
Mapped by significant region |
IEA
|
C11orf83 |
chromosome 11 open reading frame 83 |
Mapped by significant region |
IEA
|
CST6 |
cystatin E/M |
Mapped by significant region |
IEA
|
PLA2G10 |
phospholipase A2, group X |
Mapped by significant region; Mapped by PBA pathway |
TAS
|
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
Mapped by LD-proxy |
NAS[14718574]
|
TPSAB1 |
tryptase alpha/beta 1 |
Mapped by significant region |
TAS
|
FGF4 |
fibroblast growth factor 4 |
Mapped by significant region |
TAS
|
CLEC3A |
C-type lectin domain family 3, member A |
Mapped by significant region |
IEA
|
NPY |
neuropeptide Y |
Mapped by CNV; Mapped by significant region |
TAS
|
IL6 |
interleukin 6 (interferon, beta 2) |
Mapped by significant region |
TAS
|
ARSJ |
arylsulfatase family, member J |
Mapped by CNV |
IEA
|
CHRDL2 |
chordin-like 2 |
Mapped by significant region |
IEA
|
PDGFD |
platelet derived growth factor D |
Mapped by significant region |
TAS
|
SAAL1 |
serum amyloid A-like 1 |
Mapped by LD-proxy |
IEA
|
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid) |
Mapped by PBA pathway |
TAS
|
GLB1L2 |
galactosidase, beta 1-like 2 |
Mapped by CNV; Mapped by significant region |
IEA
|
REG1B |
regenerating islet-derived 1 beta |
Mapped by CNV |
IEA
|
SIGLEC1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
Mapped by CNV |
IEA
|
PLA2G1B |
phospholipase A2, group IB (pancreas) |
Mapped by PBA pathway |
TAS
|
ENDOD1 |
endonuclease domain containing 1 |
Mapped by significant region |
IEA
|
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
Mapped by LD-proxy |
TAS
|
C9 |
complement component 9 |
Mapped by significant region |
TAS
|
WNT6 |
wingless-type MMTV integration site family, member 6 |
Mapped by significant region |
NAS
|
APOA1 |
apolipoprotein A-I |
Mapped by significant region |
TAS
|
TBC1D15 |
TBC1 domain family, member 15 |
Mapped by LD-proxy |
IEA
|
GPHA2 |
glycoprotein hormone alpha 2 |
Mapped by significant region |
IDA[12089349]
|
C6 |
complement component 6 |
Mapped by significant region |
TAS
|
IGFALS |
insulin-like growth factor binding protein, acid labile subunit |
Mapped by significant region |
NAS[14718574]; TAS
|
TSKU |
tsukushi, small leucine rich proteoglycan |
Mapped by significant region |
IEA
|
EDEM2 |
ER degradation enhancer, mannosidase alpha-like 2 |
Mapped by Literature SNP |
IEA
|
ADAMTS2 |
ADAM metallopeptidase with thrombospondin type 1 motif, 2 |
Mapped by Literature SNP; Mapped by CNV |
TAS
|
CRB2 |
crumbs family member 2 |
Mapped by significant region |
IEA
|
ZG16B |
zymogen granule protein 16B |
Mapped by significant region |
IEA
|
OLFML2A |
olfactomedin-like 2A |
Mapped by significant region |
IEA
|
LGI2 |
leucine-rich repeat LGI family, member 2 |
Mapped by CNV |
IEA
|
PRG2 |
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) |
Mapped by significant region |
IEA
|
KRTAP5-8 |
keratin associated protein 5-8 |
Mapped by significant region |
NAS
|
TXN |
thioredoxin |
Mapped by significant region |
IEA
|
NXPE1 |
neurexophilin and PC-esterase domain family, member 1 |
Mapped by significant region |
IEA
|
TMPRSS11D |
transmembrane protease, serine 11D |
Mapped by significant region |
IEA
|
CABP4 |
calcium binding protein 4 |
Mapped by significant region |
NAS[16960802]
|
SEPP1 |
selenoprotein P, plasma, 1 |
Mapped by CNV; Mapped by significant region |
NAS[14718574]
|
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
Mapped by significant region |
NAS[14718574]; TAS
|
CCDC126 |
coiled-coil domain containing 126 |
Mapped by CNV; Mapped by significant region |
IEA
|
FCGR3A |
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
Mapped by CNV |
IEA
|
DNASE1L2 |
deoxyribonuclease I-like 2 |
Mapped by significant region |
IEA
|
TPSD1 |
tryptase delta 1 |
Mapped by significant region |
IEA
|
DSC3 |
desmocollin 3 |
Mapped by significant region |
IEA
|
PATE3 |
prostate and testis expressed 3 |
Mapped by significant region |
IEA
|
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
Mapped by significant region |
IEA
|
DNASE1 |
deoxyribonuclease I |
Mapped by significant region |
IEA
|
HPX |
hemopexin |
Mapped by CNV |
NAS[14718574]
|
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
Mapped by LD-proxy |
IEA
|
GNPTG |
N-acetylglucosamine-1-phosphate transferase, gamma subunit |
Mapped by significant region |
IEA
|
REG3G |
regenerating islet-derived 3 gamma |
Mapped by CNV |
IEA
|
PRSS27 |
protease, serine 27 |
Mapped by significant region |
IEA
|
XYLT1 |
xylosyltransferase I |
Mapped by CNV; Mapped by significant region |
IEA
|
CCL27 |
chemokine (C-C motif) ligand 27 |
Mapped by LD-proxy |
TAS
|
CTGF |
connective tissue growth factor |
Mapped by significant region |
TAS
|
NXPH4 |
neurexophilin 4 |
Mapped by CNV |
IEA
|
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
Mapped by CNV |
NAS[14718574]
|
CLCF1 |
cardiotrophin-like cytokine factor 1 |
Mapped by significant region |
IDA[10966616]; NAS[10448081]
|
GFER |
growth factor, augmenter of liver regeneration |
Mapped by significant region |
IEA
|
ENPP3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
Mapped by significant region |
IEA
|
TMPRSS11B |
transmembrane protease, serine 11B |
Mapped by significant region |
IEA
|
VWA3A |
von Willebrand factor A domain containing 3A |
Mapped by CNV; Mapped by significant region |
IEA
|
FGF3 |
fibroblast growth factor 3 |
Mapped by significant region |
TAS
|
CRISPLD2 |
cysteine-rich secretory protein LCCL domain containing 2 |
Mapped by CNV; Mapped by significant region |
IEA
|
RESP18 |
regulated endocrine-specific protein 18 |
Mapped by significant region |
IEA
|
IGHV4OR15-8 |
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
Mapped by significant region |
IEA
|
F2RL2 |
coagulation factor II (thrombin) receptor-like 2 |
Mapped by PBA pathway |
TAS
|
CTRB1 |
chymotrypsinogen B1 |
Mapped by significant region |
NAS; TAS
|
VWCE |
von Willebrand factor C and EGF domains |
Mapped by significant region |
IEA
|
FOLR4 |
folate receptor 4, delta (putative) |
Mapped by significant region |
IEA
|
PON2 |
paraoxonase 2 |
Mapped by PBA pathway |
IEA
|
DEFB136 |
defensin, beta 136 |
Mapped by CNV |
IEA
|
PRSS22 |
protease, serine, 22 |
Mapped by significant region |
IEA
|
TLL1 |
tolloid-like 1 |
Mapped by Literature SNP |
TAS
|
COL15A1 |
collagen, type XV, alpha 1 |
Mapped by significant region |
TAS
|
DEAF1 |
DEAF1 transcription factor |
Mapped by Literature SNP |
IEA
|
FGF9 |
fibroblast growth factor 9 |
Mapped by significant region |
TAS
|
EYS |
eyes shut homolog (Drosophila) |
Mapped by significant region |
IEA
|
APOA5 |
apolipoprotein A-V |
Mapped by significant region |
IDA[11577099]; TAS
|
WFIKKN1 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 |
Mapped by significant region |
IEA
|
LIFR |
leukemia inhibitory factor receptor alpha |
Mapped by significant region |
IEA
|
TCN1 |
transcobalamin I (vitamin B12 binding protein, R binder family) |
Mapped by significant region |
IEA
|
DHRS11 |
dehydrogenase/reductase (SDR family) member 11 |
Mapped by CNV |
IEA
|
FGF19 |
fibroblast growth factor 19 |
Mapped by significant region |
TAS
|
GHR |
growth hormone receptor |
Mapped by CNV; Mapped by significant region |
TAS
|
OMD |
osteomodulin |
Mapped by significant region |
TAS
|
TMPRSS11A |
transmembrane protease, serine 11A |
Mapped by significant region |
IEA
|
TTR |
transthyretin |
Mapped by significant region |
NAS[14718574]; TAS
|
PRLR |
prolactin receptor |
Mapped by significant region |
IEA
|
ST14 |
suppression of tumorigenicity 14 (colon carcinoma) |
Mapped by significant region |
IEA
|
VEGFB |
vascular endothelial growth factor B |
Mapped by significant region |
TAS
|
IGFBP5 |
insulin-like growth factor binding protein 5 |
Mapped by significant region |
NAS[14718574]; TAS
|
CASP1 |
caspase 1, apoptosis-related cysteine peptidase |
Mapped by significant region |
IEA
|
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
Mapped by significant region |
TAS
|
C7 |
complement component 7 |
Mapped by significant region |
TAS
|
APOC2 |
apolipoprotein C-II |
Mapped by PBA pathway |
NAS[14718574]; TAS
|
C5orf55 |
chromosome 5 open reading frame 55 |
Mapped by significant region |
IEA
|
CTF1 |
cardiotrophin 1 |
Mapped by CNV |
TAS[7862649]
|
CLEC19A |
C-type lectin domain family 19, member A |
Mapped by significant region |
IEA
|
CLEC18B |
C-type lectin domain family 18, member B |
Mapped by significant region |
IEA
|
GP2 |
glycoprotein 2 (zymogen granule membrane) |
Mapped by significant region |
IEA
|
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
Mapped by significant region |
ISS; TAS
|
C11orf45 |
chromosome 11 open reading frame 45 |
Mapped by significant region |
IEA
|
OLFML1 |
olfactomedin-like 1 |
Mapped by CNV |
IEA
|
MMP10 |
matrix metallopeptidase 10 (stromelysin 2) |
Mapped by significant region |
TAS
|
AMBP |
alpha-1-microglobulin/bikunin precursor |
Mapped by significant region |
NAS[11877257]
|
ACHE |
acetylcholinesterase (Yt blood group) |
Mapped by PBA pathway |
IDA[1517212]; TAS[11283752]
|
INHA |
inhibin, alpha |
Mapped by significant region |
TAS[12456957]
|
TLR9 |
toll-like receptor 9 |
Mapped by LD-proxy |
NAS[11130078]
|
C9orf47 |
chromosome 9 open reading frame 47 |
Mapped by significant region |
IEA
|
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
Mapped by PBA pathway |
TAS
|
NMS |
neuromedin S |
Mapped by CNV |
TAS
|
TMPRSS11F |
transmembrane protease, serine 11F |
Mapped by significant region |
IEA
|
KCP |
kielin/chordin-like protein |
Mapped by Literature SNP |
IEA
|
REG1A |
regenerating islet-derived 1 alpha |
Mapped by CNV |
IEA
|
SCG5 |
secretogranin V (7B2 protein) |
Mapped by CNV; Mapped by significant region |
IEA
|
PRSS53 |
protease, serine, 53 |
Mapped by CNV |
IEA
|
LRSAM1 |
leucine rich repeat and sterile alpha motif containing 1 |
Mapped by significant region |
IEA
|
PLA2G2E |
phospholipase A2, group IIE |
Mapped by PBA pathway |
TAS
|
SERPINC1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
Mapped by significant region |
NAS[14718574]; TAS
|
PNLIP |
pancreatic lipase |
Mapped by PBA pathway |
TAS
|
MTRNR2L1 |
MT-RNR2-like 1 |
Mapped by significant region |
IEA
|
SCGB1D4 |
secretoglobin, family 1D, member 4 |
Mapped by significant region |
IEA
|
MMP3 |
matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
Mapped by significant region |
TAS
|
C16orf89 |
chromosome 16 open reading frame 89 |
Mapped by significant region |
IEA
|
PNLIPRP2 |
pancreatic lipase-related protein 2 |
Mapped by PBA pathway |
TAS
|
PLA2G2D |
phospholipase A2, group IID |
Mapped by PBA pathway |
TAS
|
FN1 |
fibronectin 1 |
Mapped by significant region |
NAS[14718574]; TAS
|
ABHD15 |
abhydrolase domain containing 15 |
Mapped by LD-proxy |
IEA
|
STRCP1 |
stereocilin pseudogene 1 |
Mapped by LD-proxy |
IEA
|
INS |
insulin |
Mapped by Literature SNP |
IC[7556975]; TAS
|
LAMC2 |
laminin, gamma 2 |
Mapped by significant region |
TAS
|
APOA4 |
apolipoprotein A-IV |
Mapped by significant region |
NAS[14718574]; TAS
|
C4orf26 |
chromosome 4 open reading frame 26 |
Mapped by CNV |
IEA
|
PAPPA |
pregnancy-associated plasma protein A, pappalysin 1 |
Mapped by significant region |
IDA[10077652]; NAS[10913121]; TAS
|
FOLR1 |
folate receptor 1 (adult) |
Mapped by significant region |
IEA
|
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
Mapped by significant region |
ISS
|
MTRNR2L4 |
MT-RNR2-like 4 |
Mapped by significant region |
IEA
|
NXPE4 |
neurexophilin and PC-esterase domain family, member 4 |
Mapped by significant region |
IEA
|
PVRL1 |
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
Mapped by significant region |
IEA
|
C3orf58 |
chromosome 3 open reading frame 58 |
Mapped by LD-proxy |
IEA
|
ITIH1 |
inter-alpha-trypsin inhibitor heavy chain 1 |
Mapped by LD-proxy |
NAS[14718574]
|
CHST9 |
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
Mapped by significant region |
IEA
|
MMP13 |
matrix metallopeptidase 13 (collagenase 3) |
Mapped by significant region |
TAS
|
LAMA3 |
laminin, alpha 3 |
Mapped by significant region |
TAS
|
GSN |
gelsolin |
Mapped by significant region; Mapped by PBA pathway |
IDA[3020431]; ISS; NAS[14718574]; TAS
|
APOC3 |
apolipoprotein C-III |
Mapped by significant region |
TAS
|
CFC1 |
cripto, FRL-1, cryptic family 1 |
Mapped by significant region |
IEA
|
AOAH |
acyloxyacyl hydrolase (neutrophil) |
Mapped by PBA pathway |
IEA
|
BTBD17 |
BTB (POZ) domain containing 17 |
Mapped by CNV |
IEA
|
CES5A |
carboxylesterase 5A |
Mapped by LD-proxy |
IEA
|
SCGB3A1 |
secretoglobin, family 3A, member 1 |
Mapped by CNV |
NAS[11481438]
|
TUBA4A |
tubulin, alpha 4a |
Mapped by significant region |
TAS
|
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
Mapped by significant region |
IEA
|
CMA1 |
chymase 1, mast cell |
Mapped by significant region |
TAS
|
FCGR3B |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
Mapped by CNV |
IEA
|
LTBP3 |
latent transforming growth factor beta binding protein 3 |
Mapped by significant region |
IEA
|
IGHV1OR15-1 |
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
Mapped by significant region |
NAS[2841108]
|
SEMA3E |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
Mapped by CNV |
TAS
|
PRSS29P |
protease, serine, 29, pseudogene |
Mapped by significant region |
IEA
|
CCL28 |
chemokine (C-C motif) ligand 28 |
Mapped by significant region |
TAS
|
C5 |
complement component 5 |
Mapped by significant region |
TAS
|
NCAM1 |
neural cell adhesion molecule 1 |
Mapped by significant region |
IEA
|
TNC |
tenascin C |
Mapped by significant region |
TAS
|
TPSB2 |
tryptase beta 2 (gene/pseudogene) |
Mapped by significant region |
NAS
|
IL7R |
interleukin 7 receptor |
Mapped by significant region |
IEA
|
PLA2G3 |
phospholipase A2, group III |
Mapped by PBA pathway |
TAS
|
F10 |
coagulation factor X |
Mapped by CNV |
NAS[14718574]; TAS
|
GRP |
gastrin-releasing peptide |
Mapped by significant region |
TAS
|
C10orf99 |
chromosome 10 open reading frame 99 |
Mapped by CNV |
IEA
|
LIPF |
lipase, gastric |
Mapped by PBA pathway |
IEA
|
CTSG |
cathepsin G |
Mapped by significant region |
TAS
|
NELL1 |
NEL-like 1 (chicken) |
Mapped by CNV |
IEA
|
NMU |
neuromedin U |
Mapped by LD-proxy |
TAS
|
COL27A1 |
collagen, type XXVII, alpha 1 |
Mapped by significant region |
TAS
|
FOLR3 |
folate receptor 3 (gamma) |
Mapped by significant region |
IEA
|
DEFB108B |
defensin, beta 108B |
Mapped by significant region |
IEA
|
GAL |
galanin/GMAP prepropeptide |
Mapped by CNV; Mapped by significant region |
TAS
|
MMP11 |
matrix metallopeptidase 11 (stromelysin 3) |
Mapped by CNV |
TAS
|
NPC1 |
Niemann-Pick disease, type C1 |
Mapped by significant region |
ISS
|
TMPRSS11E |
transmembrane protease, serine 11E |
Mapped by significant region |
IEA
|
ISM1 |
isthmin 1, angiogenesis inhibitor |
Mapped by CNV |
IEA
|
COL10A1 |
collagen, type X, alpha 1 |
Mapped by significant region |
TAS
|
PRAP1 |
proline-rich acidic protein 1 |
Mapped by Literature SNP; Mapped by CNV |
IEA
|
SERPINI2 |
serpin peptidase inhibitor, clade I (pancpin), member 2 |
Mapped by CNV |
IEA
|
ORM1 |
orosomucoid 1 |
Mapped by significant region |
NAS[14718574]
|
FLT4 |
fms-related tyrosine kinase 4 |
Mapped by CNV |
IEA
|
FOLR2 |
folate receptor 2 (fetal) |
Mapped by significant region |
IEA
|
OGN |
osteoglycin |
Mapped by significant region |
TAS
|
NPW |
neuropeptide W |
Mapped by significant region |
TAS
|
PGA5 |
pepsinogen 5, group I (pepsinogen A) |
Mapped by significant region |
IEA
|
C5orf38 |
chromosome 5 open reading frame 38 |
Mapped by significant region |
IEA
|
LAMA2 |
laminin, alpha 2 |
Mapped by CNV; Mapped by significant region |
TAS
|
MMP8 |
matrix metallopeptidase 8 (neutrophil collagenase) |
Mapped by significant region |
TAS
|
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
Mapped by significant region |
TAS
|
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
Mapped by CNV |
TAS
|
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
Mapped by CNV |
IDA[12782713]
|
CTRB2 |
chymotrypsinogen B2 |
Mapped by significant region |
TAS
|
SERPINI1 |
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
Mapped by CNV |
IEA
|
PNLIPRP1 |
pancreatic lipase-related protein 1 |
Mapped by PBA pathway |
TAS[1379598]
|
GALNT1 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
Mapped by significant region |
IEA
|
COL8A1 |
collagen, type VIII, alpha 1 |
Mapped by CNV |
TAS
|
BTC |
betacellulin |
Mapped by CNV |
TAS
|
SIAE |
sialic acid acetylesterase |
Mapped by significant region |
IEA
|
IGLL1 |
immunoglobulin lambda-like polypeptide 1 |
Mapped by CNV |
IEA
|
PRSS23 |
protease, serine, 23 |
Mapped by significant region |
IEA
|
KARS |
lysyl-tRNA synthetase |
Mapped by significant region |
IEA
|
PLA2G5 |
phospholipase A2, group V |
Mapped by PBA pathway |
TAS
|
IL18BP |
interleukin 18 binding protein |
Mapped by significant region |
TAS[10023777]
|
NPIPB15 |
nuclear pore complex interacting protein family, member B15 |
Mapped by significant region |
IEA
|
ACP6 |
acid phosphatase 6, lysophosphatidic |
Mapped by CNV |
IEA
|
OLFML2B |
olfactomedin-like 2B |
Mapped by CNV |
IEA
|
FCRLA |
Fc receptor-like A |
Mapped by CNV |
IEA
|
HABP4 |
hyaluronan binding protein 4 |
Mapped by significant region |
TAS
|
DEFB134 |
defensin, beta 134 |
Mapped by CNV |
IEA
|
GLB1L |
galactosidase, beta 1-like |
Mapped by significant region |
IEA
|
PDZD2 |
PDZ domain containing 2 |
Mapped by significant region |
ISS[12671685]
|
C17orf77 |
chromosome 17 open reading frame 77 |
Mapped by CNV |
IEA
|
CFC1B |
cripto, FRL-1, cryptic family 1B |
Mapped by significant region |
IEA
|
POTEKP |
POTE ankyrin domain family, member K, pseudogene |
Mapped by significant region |
TAS
|